Therapeutic interventions associated with improvements in the quality of life of patients with fibromyalgia: a systematic review




Fibromyalgia; Intervention; Patient; Quality of life.


Fibromyalgia is a syndrome characterized by multifaceted symptoms that negatively impact the quality of life. With greater prevalence in women, the syndrome is manifested through widespread pain, fatigue, anxiety, and depression. While different interventions and guidelines for clinical management and diagnosis have been proposed, these are fraught with limiting factors due to the heterogeneity of associated symptoms, chronicity, and therapies with significative side effects. Based on the above, the objective of this study aims to evaluate the therapeutic interventions that improve the different domains of quality of life in patients with fibromyalgia. The research was conducted through systematic searches in the PUBMED, SCOPUS, LILACS and Web of Science databases between March 1, 2020, and May 08, 2021. Articles in Portuguese, English or Spanish were considered for analysis. To verify the risk of bias in each study, the levels of evidence were judged by two independent reviewers using the Cochrane collaboration tool. Articles in Portuguese, English or Spanish were considered for analysis. The scope of this review consisted of thirteen randomized clinical trials that met the pre-established inclusion criteria. The studies reviewed included 3,339 patients with a pre-established diagnosis of fibromyalgia, 92.2% of whom were female. Overall, fifteen interventions were observed that showed results for overall QOL and its physical and mental domains. The results showed high-quality evidence with positive findings for pain, physical functioning, anxiety, and depression with pharmacological and behavioral interventions. There is high-quality evidence supporting pregabalin for overall quality of life and the physical domain (pain and function), cognitive behavior therapy, and milnacipran for the physical domain of quality of life (pain and function), and moderate-quality evidence supporting cognitive behavioral therapy for the domain psychological (anxiety and depression).


Aguglia, A., Salvi, V., Maina, G., Rossetto, I., & Aguglia, E. (2011). Fibromyalgia syndrome and depressive symptoms: Comorbidity and clinical correlates. Journal of Affective Disorders, 128(3), 262–266.

AJ, B., SC, W., RS, R., Bidonde, J., CL, S., LA, S., Danyliw, A., Sawant, A., V, D. B.-H., Rader, T., & TJ, O. (2013). Resistance exercise training for fibromyalgia. Cochrane Database of Systematic Reviews, 12, 1–110.

Alda, M., Luciano, J. V., Andrés, E., Serrano-Blanco, A., Rodero, B., del Hoyo, Y. L., Roca, M., Moreno, S., Magallón, R., & García-Campayo, J. (2011). Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: A randomised controlled trial. Arthritis Research and Therapy, 13(5), R173.

Arnold, M. J. (2017). Pregabalin for Fibromyalgia Pain in Adults. American Family Physician, 96(5), 291–292.

Arnold, R., Ranchor, A. V., Sanderman, R., Kempen, G. I. J. M., Ormel, J., & Suurmeijer, T. P. B. M. (2004). The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Quality of Life Research, 13(5), 883–896.

Bai, Y., Guo, Y., Wang, H., Chen, B., Wang, Z., Liu, Y., Zhao, X., & Li, Y. (2014). Efficacy of acupuncture on fibromyalgia syndrome: A Meta-analysis. Journal of Traditional Chinese Medicine, 34(4), 381–391.

Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007). An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders, 8, 1–11.

Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2018). Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta-analysis of randomized controlled trials. European Journal of Pain (United Kingdom), 22(2), 242–260.

Bernardy, Kathrin, Füber, N., Köllner, V., & Häuser, W. (2010). Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - A systematic review and metaanalysis of randomized controlled trials. Journal of Rheumatology, 37(10), 1991–2005.

Boomershine, C. S., & Crofford, L. J. (2009). A symptom-based approach to pharmacologic management of fibromyalgia. Nature Reviews Rheumatology, 5(4), 191–199.

Branco, J. C., Cherin, P., Montagne, A., & Bouroubi, A. (2011). Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study. Journal of Rheumatology, 38(7), 1403–1412.

Buckhardt, C., Goldenberg, D., Crofford, L., Gerwin, R., Gowens, S., Jackson, K., Kugel, P., McCarberg, W., Rudin, N., Schanberg, L., Taylor, A., & Turk, D. (2005). Guideline for the management of fibromyalgia syndrome pain in adults and children (Clinical practice guideline; no.4). Glenviwq, IL, American Pain Society. guideline- Fibromyalgia.pdf

Busch, A. J., Barber, K. A. R., Overend, T. J., Peloso, P. M. J., & Schachter, C. L. (2007). Exercise for treating fibromyalgia syndrome. Cochrane Database of Systematic Reviews, 4.

Collazo, E., Ramírez Urbano, I., & González-Ripoll, C. (2015). Ensayo clínico sobre la eficacia de varios procedimientos terapéuticos en el alivio del dolor en pacientes con fibromialgia. Revista Internacional de Acupuntura, 9(3), 87–94.

Cording, M., Derry, S., Phillips, T., Moore, R. A., & Wiffen, P. J. (2015). Milnacipran for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews, 2017(5).

Curran, M. P. (2009). Duloxetine. 69(9), 1217–1227.

Deare, J. C., Zheng, Z., Xue, C. C. L., Liu, J. P., Shang, J., Scott, S. W., & Littlejohn, G. (2013). Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews, 2013(5).

Fitzcharles, M. A., Ste-Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Choinière, M., Ko, G., Moulin, D. E., Panopalis, P., Proulx, J., & Shir, Y. (2013). Canadian pain society and canadian rheumatology association recommendations for rational care of persons with fibromyalgia. A summary report. Journal of Rheumatology, 40(8), 1388–1393.

Gelonch, O., Garolera, M., Valls, J., Castella, G., Varela, O., Rossello, L., & Pifarre, J. (2018). The effect of depressive symptoms on cognition in patients with fibromyalgia. PLoS ONE, 13(7), 1–20.

Glombiewski, J. A., Sawyer, A. T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S. G. (2010). Psychological treatments for fibromyalgia: A meta-analysis. Pain, 151(2), 280–295.

Häuser, W., Ablin, J., Fitzcharles, M. A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015). Fibromyalgia. Nature Reviews Disease Primers, 1(August), 1–16.

Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L., & Sterne, J. A. C. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Online), 343(7829), 1–9.

Kashikar-Zuck, S., Ting, T. V., Arnold, L. M., Bean, J., Powers, S. W., Graham, T. B., Passo, M. H., Schikler, K. N., Hashkes, P. J., Spalding, S., Lynch-Jordan, A. M., Banez, G., Richards, M. M., & Lovell, D. J. (2012). Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: A multisite, single-blind, randomized, controlled clinical trial. Arthritis and Rheumatism, 64(1), 297–305.

Larsson, A., Palstam, A., Löfgren, M., Ernberg, M., Bjersing, J., Bileviciute-Ljungar, I., Gerdle, B., Kosek, E., & Mannerkorpi, K. (2015). Resistance exercise improves muscle strength, health status and pain intensity in fibromyalgia-a randomized controlled trial. Arthritis Research and Therapy, 17(1).

Lorena, S. B. de, Pimentel, E. A. dos S., Fernandes, V. M., Pedrosa, M. B., Ranzolin, A., & Duarte, A. L. B. P. (2016). Evaluation of pain and quality of life of fibromyalgia patients. Revista Dor, 17(1), 8–11.

Lumley, M. A., Schubiner, H., Lockhart, N. A., Kidwell, K. M., Harte, S. E., Clauw, D. J., & Williams, D. A. (2017). Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: A cluster-randomized controlled trial. Pain, 158(12), 2354–2363.

Lunn, M. P. T., Hughes, R. A. C., & Wiffen, P. J. (2014). Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews, 2014(1).

Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Flub, E., Choy, E., Kosek, E., Amris, K., Branco, J., Dincer, F., Leino-Arjas, P., Longle, K., McCarthy, G. M., Makri, S., Perrot, S., Sarzi-Puttini, P., Taylor, A., & Jones, G. T. (2017). EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases, 76(2), 318–328.

Marques, A. P., Santo, A. de S. do E., Berssaneti, A. A., Matsutani, L. A., & Yuan, S. L. K. (2017). Prevalence of fibromyalgia: literature review update. Revista Brasileira de Reumatologia (English Edition), 57(4), 356–363.

McIntyre, A., Paisley, D., Kouassi, E., & Gendron, A. (2014). Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: A double-blind, randomized, placebo-controlled study. Arthritis and Rheumatology, 66(2), 451–461.

Miki, K., Murakami, M., Oka, H., Onozawa, K., Yoshida, S., & Osada, K. (2016). Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression. Pain, 157(9), 2089–2096.

Murakami, M., Osada, K., Mizuno, H., Ochiai, T., Alev, L., & Nishioka, K. (2015). A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Research and Therapy, 17(1), 1–13.

Nakagawa, A., Watanabe, N., Omori, I. M., Cipriani, A., Barbui, C., McGuire, H., Churchill, R., & Furukawa, T. A. (2007). Milnacipran versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews, 2.

Obata, H. (2017). Analgesic mechanisms of antidepressants for neuropathic pain. International Journal of Molecular Sciences, 18(11).

Ohta, H., Oka, H., Usui, C., Ohkura, M., Suzuki, M., & Nishioka, K. (2012). A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Research and Therapy, 14(5), R217.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ, 372.

Perahia, D. G. S., Pritchett, Y. L., Desaiah, D., & Raskin, J. (2006). Efficacy of duloxetine in painful symptoms: An analgesic or antidepressant effect? International Clinical Psychopharmacology, 21(6), 311–317.

Perrot, S., & Russell, I. J. (2014). More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms. European Journal of Pain (United Kingdom), 18(8), 1067–1080.

Perry, R., Leach, V., Davies, P., Penfold, C., Ness, A., & Churchill, R. (2017). An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools. Systematic Reviews, 6(1).

Pilkington, K. (2010). Anxiety, depression and acupuncture: A review of the clinical research. Autonomic Neuroscience: Basic and Clinical, 157(1–2), 91–95.

Schiltenwolf, M., Eidmann, U., Köllner, V., Kühn, T., Offenbächer, M., Petzke, F., Sarholz, M., Weigl, M., Wolf, B., & Häuser, W. (2017). Multimodal therapy of fibromyalgia syndrome: Updated guidelines 2017 and overview of systematic review articles. Schmerz, 31(3), 285–288.

Schmidt, S., Grossman, P., Schwarzer, B., Jena, S., Naumann, J., & Walach, H. (2011). Treating fibromyalgia with mindfulness-based stress reduction: Results from a 3-armed randomized controlled trial. Pain, 152(2), 361–369.

Seehusen, D. A., & Bain, R. (2017). Antipsychotics for Fibromyalgia in Adults. American Family Physician, 96(3).

Staud, R., & Rodriguez, M. E. (2006). Mechanisms of disease: Pain in fibromyalgia syndrome. Nature Clinical Practice Rheumatology, 2(2), 90–98.

Suhr, J. A. (2003). Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain. Journal of Psychosomatic Research, 55(4), 321–329.

Terhorst, L., Schneider, M. J., Kim, K. H., Goozdich, L. M., & Stilley, C. S. (2011). Complementary and alternative medicine in the treatment of pain in fibromyalgia: A systematic review of randomized controlled trials. Journal of Manipulative and Physiological Therapeutics, 34(7), 483–496.

Theadom, A., Cropley, M., Smith, H. E., Feigin, V. L., & Mcpherson, K. (2015). Mind and body therapy for fibromyalgia. Cochrane Database of Systematic Reviews, 2015(4).

Tzadok, R., & Ablin, J. N. (2020). Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Research and Management, 2020.

Vas, J., Santos-Rey, K., Navarro-Pablo, R., Modesto, M., Aguilar, I., Campos, M. Á., Aguilar-Velasco, J. F., Romero, M., Párraga, P., Hervás, V., Santamaría, O., Márquez-Zurita, C., & Rivas-Ruiz, F. (2016). Acupuncture for fibromyalgia in primary care: A randomised controlled trial. Acupuncture in Medicine, 34(4), 257–266.

Wang, C., Schmid, C. H., Fielding, R. A., Harvey, W. F., Reid, K. F., Price, L. L., Driban, J. B., Kalish, R., Rones, R., & McAlindon, T. (2018). Effect of tai chi versus aerobic exercise for fibromyalgia: Comparative effectiveness randomized controlled trial. BMJ (Online), 360, 1–14.

Welsch, P., Bernardy, K., Derry, S., Moore, R. A., & Häuser, W. (2018). Mirtazapine for fibromyalgia in adults. Cochrane Database of Systematic Reviews, 2018(8).

Williams, D. A., & Arnold, L. M. (2011). Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care and Research, 63(SUPPL. 11), 86–97.

Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research, 62(5), 600–610.

Zhang, X. C., Chen, H., Xu, W. T., Song, Y. Y., Gu, Y. H., & Ni, G. X. (2019). Acupuncture therapy for fibromyalgia: A systematic review and meta-analysis of randomized controlled trials. Journal of Pain Research, 12, 527–542.




How to Cite

SANTOS, T. C. A. .; GOMES, I. A. .; MENEZES, P. dos P. . Therapeutic interventions associated with improvements in the quality of life of patients with fibromyalgia: a systematic review. Research, Society and Development, [S. l.], v. 11, n. 9, p. e23511931684, 2022. DOI: 10.33448/rsd-v11i9.31684. Disponível em: Acesso em: 19 aug. 2022.



Review Article